Posts by: Charles Moore

Charles Moore

Charles Moore is a syndicated columnist for several major Canadian print newspapers and the Science and Research Section editor for CF News Today.

May 26, 2016May 26, 2016

AbbVie Showcases IBD Therapies at Digestive Disease Week Annual Meeting

Crohn's Disease, IBD News, News, Ulcerative colitis

North Chicago, Illinois based multinational biopharmaceutical company AbbVie presented 13 abstracts at the Digestive Disease Week (DDW) Annual Meeting held May 21-24, 2016, at San Diego, California. Abstracts presented addressed ... Read more

April 13, 2016September 28, 2016

Celltrion’s Inflectra, a Biosimilar to Treat Ulcerative Colitis and Crohn’s Disease, Gets FDA Approval

News

Celltrion recently announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of its Inflectra (biosimilar infliximab) product for all indications of the reference product, ... Read more

January 26, 2016September 28, 2016

Treatments for Bowel Diseases to Be Focus at New GeneThera Lab Facility

News

Westminster, Colorado based GeneThera Inc., a biotechnology company specializing in zoonotic diseases that can afflict both animals and people, recently announced it will have a new laboratory facility operational this ... Read more

September 4, 2015September 28, 2016

Genetic Overlapping in IBD, Other Autoimmune Diseases May Suggest Potential For Common Therapies

IBD News, News

A team of scientists led by Hakon Hakonarson, MD, PhD, director of the Center for Applied Genomics at The Children’s Hospital of Philadelphia (CHOP) Center for Applied Genomics in a ... Read more

August 5, 2015September 6, 2016

Weightless Space Environment Could Give You A Bad Case Of Diarrhea (Or Worse)

IBD News, News

Research reported in the August 2015 issue of The Federation Of American Societies For Experimental Biology (FASEB) Journal suggests that in weightless environments, mouse intestine microbiomes undergo changes in the balance ... Read more

July 10, 2015July 10, 2015

Stereomicroscopy 3-D Views Of Intestines Could Yield Clues To Treating Inflammatory Bowel Disease

News

A technology with roots dating back to the 19th Century is showing potential to offer new advantages for modern-day medicine. In findings published this month in the journal Nature Communications, ... Read more

July 9, 2015September 28, 2016

Tillotts Pharma AG To Acquire Global Rights for Entocort (budesonide) Outside The U.S. Under Agreement With AstraZeneca

Crohn's Disease, News

Rheinfelden, Switzerland based Tillotts Pharma AG (“Tillotts”), part of Japan’s Zeria Group, has announced its entry into an agreement in which it will acquire global rights from London based AstraZeneca ... Read more

July 8, 2015September 28, 2016

New Device to Transform Lives of Bowel Disease Patients Launched

Crohn's Disease, News, Ulcerative colitis

British medical technology firm 11health has announced UK availability of what it claims is the first ever patient-developed medical technology device. The Ostom-i Alert is projected to help the roughly ... Read more

June 10, 2015June 10, 2015

Non-Invasive Accupoint Stimulation May Offer New Bioelectronics Approach To Crohn’s Treatment

Crohn's Disease, News

An oral abstract presented on Tuesday June 9 at the International Neuromodulation Society 12th World Congress, which ran from June 6 to 11 at the Fairmont Queen Elizabeth Hotel in ... Read more

June 1, 2015June 1, 2015

Game-Changing IBD Population Health Management Platform Launched

Crohn's Disease, News

Elgin, Illinois based Sonar MD, LLC has announced the release of its Sonar MD Platform, an innovative cloud-based algorithm for secure engagement, monitoring and management of patients with chronic gastrointestinal ... Read more